Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

In-Vitro Diagnostics Market Global Briefing 2017

In-Vitro Diagnostics Market Global Briefing 2017

From $1,000.00

Including: Point-of-Care Diagnostics, Immunochemistry, Molecular Diagnostics, Microbiology, Hematology and Immunohematology
Covering: Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation


Clear selection
SKU: 1730. Categories: , .
Description

In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids.

The In-Vitro Diagnostics Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the in-vitro diagnostics market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the in-vitro diagnostics market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the in-vitro diagnostics market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

 

Scope

Markets Covered: Point-of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology and Immunohematology

Companies Mentioned: F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., bioMérieux, Sysmex Corporation, and Becton Dickinson & Company

Geographic scope: Americas, Europe, Asia, Middle East and Africa, Oceania.

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents
In-Vitro Diagnostics Market Characteristics 5
Point-of-Care Diagnostics 5
Immunochemistry Diagnostics 5
Clinical Chemistry Diagnostics 5
Molecular Diagnostics 5
Hematology Diagnostic Instruments 5
Microbiology Diagnostic Devices 6
In-Vitro Diagnostics Market Historic Growth 8
In-Vitro Diagnostics Market Forecast 9
In-Vitro Diagnostics Market Segmentation 10
In-Vitro Diagnostics Market Size, Split By Segments, 2016, $ Billion 10
Point-of-Care Diagnostics 11
Immunochemistry 11
Immunohematology 11
In-Vitro Diagnostics Market Regional and Country Comparison 12
Global In-Vitro Diagnostics Market, Split By Region, 2016 12
Global In-Vitro Diagnostics Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 13
Global In-Vitro Diagnostics Market, Split By Country, 2016 15
Global In-Vitro Diagnostics Market, Historic And Forecast Growth Rate, Split By Country, 2011-2019 16
In-Vitro Diagnostics Market Competitive Landscape 19
In-Vitro Diagnostics Market Key Mergers and Acquisitions 21
Roche Acquired GeneWEAVE 21
Thermo Fisher Scientific Acquired Life Technologies Corporation 21
Grifols Acquired Novartis Diagnostics 21
Carlyle Acquired Johnson and Johnson’s Blood Testing Unit 21
Roche Acquired Ariosa 21
Beckman Coulter Acquired Siemens Healthcare Diagnostics 21
In-Vitro Diagnostics Market Trends and Strategies 22
Strategic Collaborations And Agreements 22
New Product Launches 22
Rising Demand for Point-of-Care (POC) Testing 22
Appendix 23
NAICS Definitions of Industry Covered in this Report 23
Methodology 23
Data 23
Market Numbers 23
Competitor Market Share Data 23
Analysis 23
Verification Through Expert Interviews 24
Referencing 24
Note on Currency Conversions 24
Research Methodology 24
Abbreviations 24
Currencies 24
Research Inquiries 24
The Business Research Company 24
Executive Summary
In-Vitro Diagnostics market segments included point-of-care diagnostics, immunochemistry diagnostics, clinical chemistry diagnostics, molecular diagnostics, hematology diagnostic devices, and microbiology diagnostic devices.

The global In-Vitro Diagnostics market is expected to reach over $74 billion in 2020.

The in-vitro diagnostics market is relatively fragmented, with few global players. The top five competitors in the market made up around 70% of the total market share in 2016.

Companies in this market are working towards constant innovation in design and technology to make these devices more sensitive, user-friendly and faster. They are continuously investing funds and resources into R&D to increase the scope of their devices and also to increase their market share in the global in-vitro diagnostics market. For instance, In January 2017, Roche’s Elecsys Troponin T Gen 5 STAT blood test got approval from FDA which is used to detect heart attacks by identifying cardiac troponin, a biomarker to diagnose myocardial infarction and heart attacks. Quest Diagnostics introduced a new quantitative test for hepatitis B virus that was used to examine the patient’s response to antiviral treatments.
Get Customized Report
Please fill in your details. Our team will get back to you